| GBP millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.1 | 0.1 | 0.1 | 0.5 | 0.3 | 0.0 | −100.0% | |
| Gross profit | (0.1) | (0.1) | (0.1) | (0.5) | (0.3) | 0.0 | +100.0% | |
| Research & development | 0.1 | 0.6 | 3.1 | 2.1 | 0.4 | 0.0 | −100.0% | |
| Operating expenses | 2.0 | 1.9 | 4.9 | 4.2 | 1.4 | 0.6 | −59.2% | |
| Operating income | (2.0) | (2.0) | (4.9) | (4.6) | (1.6) | (0.6) | +65.7% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −100.0% | |
| Interest income | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | — | |
| Pre-tax income | (1.7) | (2.1) | (4.5) | (4.8) | (4.4) | (0.0) | +99.9% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (1.4) | (2.1) | (4.7) | (4.8) | (4.1) | (0.6) | +84.6% | |
| EPS, basic (per share) | (0.05) | (0.08) | (0.17) | (0.18) | (0.15) | (0.02) | +84.6% | |
| EPS, diluted (per share) | (0.05) | (0.08) | (0.17) | (0.18) | (0.15) | (0.02) | +84.6% | |
| EBITDA | (2.0) | (1.9) | (4.9) | (4.2) | (1.4) | (0.6) | +59.2% | |
| Depreciation & amortization | 0.1 | 0.1 | 0.1 | 0.5 | 0.3 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | +0.0% | |
| Weighted average diluted shares (shares) | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | 27,188,000 | +0.0% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
